the cost-effectiveness of antiretroviral treatment in khayelitsha, south africa – a primary data analysis卡雅利沙的抗逆转录病毒治疗的成本效益,南非主要数据分析.pdfVIP

Cost Effectiveness and Resource Allocation BioMed Central Research Open Access The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis 1 1 2 Susan M Cleary* , Di McIntyre and Andrew M Boulle Address: 1Health Economics Unit, School of Public Health Family Medicine, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa and 2Infectious Disease Epidemiology Unit, School of Public Health Family Medicine, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa Email: Susan M Cleary* - scleary@heu.uct.ac.za; Di McIntyre - dimac@heu.uct.ac.za; Andrew M Boulle - aboulle@phfm.uct.ac.za * Corresponding author Published: 06 December 2006 Received: 07 August 2006 Accepted: 06 December 2006 Cost Effectiveness and Resource Allocation 2006, 4:20 doi:10.1186/1478-7547-4-20 This article is available from: /content/4/1/20 © 2006 Cleary et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Given the size of the HIV epidemic in South Africa and other developing countries, scaling up antiretroviral treatment (ART) represents one of the key public health challenges of the next decade.